当前位置:首页 - 行情中心 - 富祥药业(300497) - 财务分析 - 现金流量表

富祥药业

(300497)

  

流通市值:43.82亿  总市值:53.54亿
流通股本:4.41亿   总股本:5.39亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金397,639,708.99176,922,586.121,089,100,913.39694,550,850.35
  收到的税费返还17,692,162.643,343,827.63125,746,448.82115,330,033.75
  收到其他与经营活动有关的现金61,610,523.9656,517,215.3362,710,720.9354,484,278.42
  经营活动现金流入小计476,942,395.59236,783,629.081,277,558,083.14864,365,162.52
  购买商品、接受劳务支付的现金307,223,209.83120,491,136.37777,622,813.66475,393,887.59
  支付给职工以及为职工支付的现金99,946,044.2953,365,820.3189,445,373.32143,634,470.3
  支付的各项税费14,291,930.66,397,777.2427,055,170.8723,516,153.43
  支付其他与经营活动有关的现金44,637,117.9619,879,441.295,794,781.7771,464,182.07
  经营活动现金流出小计466,098,302.68200,134,175.111,089,918,139.62714,008,693.39
  经营活动产生的现金流量净额10,844,092.9136,649,453.97187,639,943.52150,356,469.13
二、投资活动产生的现金流量:
  收回投资收到的现金62,914,367.7730,000,00030,000,000-
  取得投资收益收到的现金747,149.78115,580.821,041,873.64890,292.82
  处置固定资产、无形资产和其他长期资产收回的现金净额683,898.31134,712.431,096,540.66856,896.2
  投资活动现金流入小计64,345,415.8630,250,293.2532,138,414.31,747,189.02
  购建固定资产、无形资产和其他长期资产支付的现金154,427,047.08127,617,607.76141,748,902.45127,028,359.57
  投资支付的现金60,000,00030,000,00030,000,0006,300,000
  投资活动现金流出小计214,427,047.08157,617,607.76171,748,902.45133,328,359.57
  投资活动产生的现金流量净额-150,081,631.22-127,367,314.51-139,610,488.15-131,581,170.55
三、筹资活动产生的现金流量:
  吸收投资收到的现金27,857,10021,000,0003,500,0003,500,000
  其中:子公司吸收少数股东投资收到的现金27,857,10021,000,0003,500,0003,500,000
  取得借款收到的现金751,000,000387,000,000641,000,000542,000,000
  收到其他与筹资活动有关的现金23,733,544.823,733,544.8--
  筹资活动现金流入小计802,590,644.8431,733,544.8644,500,000545,500,000
  偿还债务支付的现金672,890,000327,000,000658,780,000515,890,000
  分配股利、利润或偿付利息支付的现金27,161,713.9914,024,250.7755,501,097.5642,864,933.01
  支付其他与筹资活动有关的现金--18,000,000-
  筹资活动现金流出小计700,051,713.99341,024,250.77732,281,097.56558,754,933.01
  筹资活动产生的现金流量净额102,538,930.8190,709,294.03-87,781,097.56-13,254,933.01
四、汇率变动对现金及现金等价物的影响577,804.41154,422.467,833,223.593,561,288.37
五、现金及现金等价物净增加额-36,120,803.09145,855.95-31,918,418.69,081,653.94
  加:期初现金及现金等价物余额548,836,848.08517,908,336.45580,755,266.68580,755,266.68
  期末现金及现金等价物余额512,716,044.99518,054,192.4548,836,848.08589,836,920.62
补充资料:
  净利润-9,992,933.47--280,451,128.86-
  资产减值准备-3,966,723.22-157,406,261.37-
  固定资产和投资性房地产折旧90,831,459.02-164,888,770.6-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧90,831,459.02-164,888,770.6-
  无形资产摊销3,501,463.63-6,201,907.35-
  处置固定资产、无形资产和其他长期资产的损失-13,578.77-103,508.54-
  固定资产报废损失316,946.5-2,187,259.66-
  公允价值变动损失--241,789.26-
  财务费用19,364,453.86-32,745,310.01-
  投资损失1,047,183.87-15,281,262.47-
  递延所得税7,222,077.43--8,158,445.21-
  其中:递延所得税资产减少7,269,518.65--7,885,054.52-
    递延所得税负债增加-47,441.22--273,390.69-
  存货的减少-49,982,564.23--44,802,791.56-
  经营性应收项目的减少27,919,497.5-13,086,964.32-
  经营性应付项目的增加-76,137,421.31-128,909,275.57-
  其他734,232.1---
  现金的期末余额512,716,044.99-548,836,848.08-
  减:现金的期初余额548,836,848.08-580,755,266.68-
  现金及现金等价物的净增加额-36,120,803.09--31,918,418.6-
公告日期2025-08-272025-04-262025-04-262024-10-24
审计意见(境内)标准无保留意见
TOP↑